Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of NKG2D expression on human peripheral blood lymphocytes. Whole blood was stained with Purified Mouse Anti-Human NKG2D (Cat. No. 552866) and APC Mouse Anti-Human CD3ε (Cat. No. 558257). Secondary staining was carried out using FITC Goat Anti-Mouse IgG/IgM (Cat. No. 552866), and erythrocytes were lysed using BD FACS™ Lysing Solution (Cat. No. 349202). The two-color fluorescent dot plot was derived from gated events using the side and forward light-scatter characteristics of viable lymphocytes.
Flow cytometric analysis of NKG2D expression on human peripheral blood lymphocytes. Whole blood was stained with Purified Mouse Anti-Human NKG2D (Cat. No. 552866) and APC Mouse Anti-Human CD3ε (Cat. No. 558257). Secondary staining was carried out using FITC Goat Anti-Mouse IgG/IgM (Cat. No. 552866), and erythrocytes were lysed using BD FACS™ Lysing Solution (Cat. No. 349202). The two-color fluorescent dot plot was derived from gated events using the side and forward light-scatter characteristics of viable lymphocytes.
Flow cytometric analysis of NKG2D expression on human peripheral blood lymphocytes. Whole blood was stained with Purified Mouse Anti-Human NKG2D (Cat. No. 552866) and APC Mouse Anti-Human CD3ε (Cat. No. 558257). Secondary staining was carried out using FITC Goat Anti-Mouse IgG/IgM (Cat. No. 552866), and erythrocytes were lysed using BD FACS™ Lysing Solution (Cat. No. 349202). The two-color fluorescent dot plot was derived from gated events using the side and forward light-scatter characteristics of viable lymphocytes.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 1D11 monoclonal antibody specifically binds to NKG2D, a 42 kDa type II transmembrane glycoprotein that is also known as CD314 and KLRK1. NKG2D is a member of the C-type lectin family and is expressed on human NK cells. This activating receptor binds strongly to several ligands including MICA and MICB and ULBP-1, -2, and -3 proteins that are expressed by different target cell types. Different from natural cytotoxicity receptor (NCR), NKG2D expression is not confined to NK cells. It is also expressed on virtually all TCR γ/δ+ and CD8+TCR α/β+ T cells. NKG2D functions as a triggering receptor involved in natural cytotoxicity mediated by normal NK cells against a variety of tumors or normal target cells. Importantly, NKG2D can complement the role of NCR in tumor cell lysis. Remarkably, the combined maskings of NCR and NKG2D can reportedly lead to a complete inhibition of NK-mediated lysis of all tumor or normal cells. The 1D11 antibody can reportedly block or stimulate the function of NKG2D-positive cells.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.